Prognostic importance of the neutrophil-to-lymphocyte ratio in malignant peritoneal mesothelioma patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

被引：0
|
作者：
Zhang Xinjing [1 ]
Gong Lei [2 ]
Li Xinbao [1 ]
Ji Zhonghe [1 ]
Yang Zhiran [1 ]
Gao Chao [1 ]
Zhang Kai [1 ]
Yan Lijun [1 ]
Yan Guojun [1 ]
Yu Junhui [1 ]
Zhang Yanbin [1 ]
An Songlin [1 ]
机构：
[1] Capital Medical University,Department of peritoneal surface surgical oncology, Beijing Shijitan Hospital
[2] Capital Medical University,Department of hepatobiliary surgical oncology, Beijing Shijitan Hospital
来源：
BMC Cancer | / 25卷 / 1期
关键词：
Prognosis; Neutrophil-to-Lymphocyte Ratio; Malignant Peritoneal Mesothelioma; Cytoreductive Surgery; Hyperthermic Intraperitoneal Chemotherapy;
D O I：
10.1186/s12885-025-13606-1
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma
    Russell, Maria C.
    Staley, Charles A.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (10) : 938 - +
  • [2] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma
    Klos, Dusan
    Hanuliak, Jan
    Lemstrova, Radka
    Mohelnikova-Duchonova, Beatrice
    Zapletalova, Jana
    Melichar, Bohuslav
    Risko, Juraj
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2023, 124 (05): : 345 - 350
  • [3] Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy (IPHC) for Malignant Peritoneal Mesothelioma (MPM)
    Blackham, A.
    Russell, G.
    Shen, P.
    Stewart, J. H.
    Levine, E. A.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 29 - 30
  • [4] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review
    Helm, J. H.
    Miura, J. T.
    Glenn, J. A.
    Marcus, R.
    Larrieux, G.
    Jayakrishnan, T. T.
    Donahue, A. E.
    Tsai, S.
    Gamblin, T. C.
    Turaga, K. K.
    Johnston, F. M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S174 - S174
  • [5] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritonel mesothelioma
    Glockzin, G.
    Lang, S. A.
    Ghali, N.
    Schlitt, H. J.
    Piso, P.
    ONKOLOGIE, 2008, 31 : 69 - 69
  • [6] Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
    Blackham, Aaron U.
    Shen, Perry
    Stewart, John H.
    Russell, Gregory B.
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (10) : 2720 - 2727
  • [7] Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma
    Huang, Y.
    Alzahrani, N. A.
    Liauw, W.
    Morris, D. L.
    EJSO, 2015, 41 (10): : 1373 - 1378
  • [8] Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
    Aaron U. Blackham
    Perry Shen
    John H. Stewart
    Gregory B. Russell
    Edward A. Levine
    Annals of Surgical Oncology, 2010, 17 : 2720 - 2727
  • [9] Value of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy to treat malignant peritoneal mesothelioma
    Wang, Tongfei
    Li, Haitao
    Ye, Biaofei
    Zhang, Da
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10712 - 10720
  • [10] Prognostic Significance of Neutrophil/Lymphocyte Ratio (NLR) and Platelet/Lymphocyte ratio (PLR) in Predicting Outcomes for Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Loh, W.
    Tan, S.
    Tan, G.
    Chia, C.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S134 - S134
12345